All Dr Michael Glickman (Director of the Marie-Josée Kravis Center for Cancer Immunobiology at MSK and professor at Weill Cornell Medicine) articles
-
NewsBCG alters bone marrow to strengthen anti-cancer response
A new study reveals that BCG, a decades-old bladder cancer treatment, reprograms the immune system at the bone marrow level, offering a new perspective into how this immunotherapy boosts the body’s defence against cancer.